RCUSArcus Biosciences, Inc.vs its industry peers
A metric-by-metric comparison of Arcus Biosciences, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RCUSThis | $2.4B#8 | — | 5.2x#10 | 73.0x#10 | -35.3%#11 | -24.7%#9 | -1169.7%#10 | -76.1%#14 | -93.0%#10 | — | -7.0%#11 | — |
| AMLX | $3.3B#1 | — | 13.6x#14 | — | -100.0%#12 | 52.0%#4 | — | -60.5%#12 | — | — | 115.2%#3 | — |
| IRON | $3.1B#2 | — | 4.8x#9 | — | — | -94.0%#13 | — | -32.9%#8 | -39.0%#6 | — | -4.1%#10 | — |
| BHC | $3.0B#3 | — | — | 0.3x#1 | 6.7%#7 | 441.3%#1 | 17.7%#3 | — | 3.7%#3 | — | — | 11.7%#1 |
| IDYA | $3.0B#4 | — | 2.8x#4 | 13.8x#5 | 3024.4%#2 | 58.6%#3 | -72.8%#5 | -10.4%#3 | — | — | — | — |
| VRDN | $2.8B#5 | — | 4.3x#6 | 40.2x#8 | 23359.9%#1 | -26.9%#10 | -512.9%#9 | -51.7%#10 | -54.5%#7 | — | 8.6%#8 | — |
| NRIX | $2.8B#6 | 10.6x#1 | 2.9x#5 | 33.6x#7 | 54.0%#4 | -36.6%#11 | -340.2%#8 | -27.3%#7 | — | — | 104.8%#4 | — |
| MBX | $2.7B#7 | — | 6.5x#12 | — | — | -40.5%#12 | — | -21.2%#6 | — | — | 166.7%#1 | — |
| BHVN | $2.4B#9 | — | — | — | — | 12.7%#6 | — | — | — | — | 5.1%#9 | — |
| PBH | $2.3B#10 | 13.9x#3 | 1.2x#2 | 2.2x#3 | -4.3%#9 | -11.3%#8 | 28.4%#1 | 9.9%#2 | 5.9%#2 | 4#1 | -18.2%#13 | — |
| IMNM | $2.3B#11 | — | 4.4x#7 | 332.7x#11 | -23.2%#10 | 27.5%#5 | -3228.8%#11 | -40.4%#9 | -72.8%#9 | — | 19.4%#6 | — |
| XNCR | $2.3B#12 | — | 4.5x#8 | 18.2x#6 | 13.7%#6 | 60.5%#2 | -141.4%#7 | -18.3%#4 | -31.5%#5 | — | 120.4%#2 | — |
| VERA | $2.2B#13 | — | 5.4x#11 | — | — | -96.9%#14 | — | -73.5%#13 | -72.7%#8 | — | 18.5%#7 | — |
| PVLA | $2.2B#14 | — | 10.2x#13 | 51.6x#9 | 65.3%#3 | -139.3%#15 | -90.2%#6 | -19.2%#5 | — | — | 99.0%#5 | — |
| PRGO | $2.2B#15 | — | 0.9x#1 | 0.5x#2 | -2.8%#8 | -729.7%#16 | -26.4%#4 | -56.7%#11 | -20.9%#4 | 4#1 | -18.0%#12 | 7.3%#2 |
| HRMY | $2.2B#16 | 12.0x#2 | 2.2x#3 | 2.5x#4 | 21.5%#5 | 9.1%#7 | 24.0%#2 | 15.9%#1 | 25.5%#1 | 4#1 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice